Analyst Ratings for Sarepta Therapeutics (SRPT)
SRPT Rating Summary
SRPT Price Target Summary
- Highest: $50.00 (BMO Capital)
- Lowest: $5.00 (H.C. Wainwright)
- Average: $22.28
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$22.28 (+27.1%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
Avg. $ Target:
$22.28 (+27.1%)
* Over Last 12-Mos
Rating Score: 4.2 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/28/2026 | Barclays » Updated 3/25/2026 |
Eliana Merle | New Coverage | Equalweight (N/A) |
20.00 (N/A) |
22.80 (17.53) |
-23.11% | Details |
| 11/5/2025 | Mizuho » Updated 3/26/2026 |
Uy Ear | Upgrade | Outperform (Neutral) |
31.00 (N/A) |
24.45 (17.53) |
-28.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
